Health
Patients with Relapsed/Refractory AML may Benefit from Treatment with Ficlatuzumab + Chemotherapy – OncoZine
Ficlatuzumab (AV-299) in combination with cytarabine (ara-C), demonstrates signs of clinical efficacy in patients with r/r AML….
Ficlatuzumab (formerly known as AV-299), a potent hepatocyte growth factor (HGF) immunoglobulin G1 (IgG1) inhibitory antibody that binds to the HGF ligand with high affinity and specificity, in combination with cytarabine (also known as arabinofuranosyl…
Continue Reading
-
General18 hours agoFerries and celebrities as pollies dash to win the west
-
Noosa News22 hours agoCSIRO, winemakers pair to breed mildew, climate-resistant grapevines
-
Noosa News19 hours agoChild killer Rick Thorburn who murdered Tiahleigh Palmer found dead in jail cell
-
Business23 hours ago3 ASX 200 stocks I’d buy and hold for the next 10 years